The weekly litigation news digest is live. Subscribe now

IP Verse

Buprenorphine Dosing Regimens - EP3215223

The patent EP3215223 was granted to Indivior UK on Jul 1, 2020. The application was filed on Nov 6, 2015 under application number EP15828368A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3215223

INDIVIOR UK
Application Number
EP15828368A
Filing Date
Nov 6, 2015
Status
Granted And Under Opposition
May 29, 2020
Publication Date
Jul 1, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ELKINGTON AND FIFEMar 30, 2021ELKINGTON AND FIFEWITHDRAWN

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO0115699
INTERNATIONAL-SEARCH-REPORTWO2011154724
INTERNATIONAL-SEARCH-REPORTWO2015136253
OPPOSITIONWO0115699
OPPOSITIONWO2011154724
OPPOSITIONWO2014016428
OPPOSITIONWO2015136253

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents